SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-503408
Filing Date
2012-12-14
Accepted
2012-12-14 16:36:08
Documents
2
Period of Report
2012-12-11
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d451085d8k.htm 8-K 23905
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d451085dex231.htm EX-23.1 4564
  Complete submission text file 0001193125-12-503408.txt   29813
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 121265985
SIC: 2834 Pharmaceutical Preparations